| Financial Year |
March 31 2023 |
| Monetary Funds |
597,342,388.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,836,475,077.06 |
| Advances to Suppliers |
58,486,496.85 |
| Other Receivables |
31,999,780.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
3,750,005.00 |
| Inventories |
1,340,543,050.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
50,268,003.75 |
| Total Current Assets |
4,641,300,808.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
18,271,379.51 |
| Long-term Equity Investment |
174,590,174.32 |
| Investment Properties |
37,315,726.09 |
| Fixed Assetes |
1,521,512,608.60 |
| Under-construction Projects |
140,276,685.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
190,818,940.83 |
| R&D expenses |
31,928,920.91 |
| Goodwill |
47,999,171.15 |
| Long-Term Deferred and Prepaid Expenses |
5,471,869.68 |
| Deferred Income Tax Assets |
230,835,862.82 |
| Other Non-Current Assets |
27,007,789.59 |
| Sub-Total of Non-Current Assets |
2,446,690,201.40 |
| Total Assets |
7,087,991,010.07 |
| Short-Term Loans |
113,036,829.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,135,618,650.73 |
| Accounts Payable |
882,873,815.89 |
| Accounts Received In Advance |
494,594.27 |
| Employee Compensation Payable |
183,207,817.46 |
| Taxes Payable |
16,537,490.00 |
| Interest Payable |
-- |
| Dividend Payable |
700,328.00 |
| Other payables |
93,427,510.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,113,477.77 |
| Other Current Liabilities |
10,745,556.07 |
| Sub-Total of Current Liabilities |
2,549,782,213.77 |
| Long-term Loans |
58,400,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
105,093,091.03 |
| Deferred Income Tax Liabilities |
26,575,774.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
239,474,224.47 |
| Total Liabilities |
2,789,256,438.24 |
| Paid-In Capital(Or Share Stock) |
476,313,680.00 |
| Capital Surplus |
973,153,066.07 |
| Surplus Reserve |
215,642,988.26 |
| LESS:Treasury Stock |
7,378,830.14 |
| Undistributed Profits |
2,648,855,853.62 |
| Minority Stockholder's Interest |
23,498,399.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,275,236,172.59 |
| Owner's Equity（Stockholder's Equity） |
4,298,734,571.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,087,991,010.07 |
